Cadrenal Therapeutics Inc...
(CVKD)
undefined
undefined%
At close: undefined
11.20
0.00%
After-hours Dec 13, 2024, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 |
Revenue | - | - |
Cost of Revenue | 1.98K | 1.27K |
Gross Profit | -1.98K | -1.27K |
Operating Income | -7.63M | -2.70M |
Interest Income | 249.09K | - |
Pretax Income | -8.36M | -6.71M |
Net Income | -8.36M | -6.71M |
Selling & General & Admin | 3.55M | 2.31M |
Research & Development | 4.08M | 392.86K |
Other Expenses | - | - |
Operating Expenses | 7.63M | 2.70M |
Interest Expense | 17.10K | 107.11K |
Selling & Marketing Expenses | - | - |
Cost & Expenses | 7.63M | 2.70M |
Income Tax | - | 4.00 |
Shares Outstanding (Basic) | 868.18K | 775.64K |
Shares Outstanding (Diluted) | 868.18K | 775.64K |
EPS (Basic) | -9.63 | -8.66 |
EPS (Diluted) | -9.63 | -8.66 |
EBITDA | -8.34M | -6.61M |
Depreciation & Amortization | 1.98K | 1.27K |